Retinal Vasculitis Associated with Ipilimumab
- PMID: 31314622
- DOI: 10.1080/09273948.2019.1610460
Retinal Vasculitis Associated with Ipilimumab
Abstract
Purpose: To describe a case of retinal vasculitis associated with ipilimumab.
Methods: Case report.
Results: A 49-year-old Caucasian man presented with anterior uveitis of the left eye. He had a history of chronic myeloid leukemia undergoing ipilimumab therapy. He was treated with topical corticosteroids and achieved inactive inflammation. Ipilimumab was stopped by his oncologist since he manifested other immune-related adverse events (irAEs). Five months later, his visual acuity decreased in his left eye and optical coherence tomography demonstrated new cystoid macular edema. Fluorescein angiography revealed diffuse capillary leakage of the left eye. He received oral prednisone with improvement of both macular edema and vascular leakage, however, both remained persistent. He received an intravitreal injection of a 0.7 mg dexamethasone implant in the left eye with subsequent resolution of macular edema and vasculitis.
Conclusions: The occurrence of retinal vasculitis with ipilimumab expands the spectrum of ocular irAEs related to immune checkpoint inhibitors.
Keywords: Immune checkpoint inhibitor; immunotherapy; ipilimumab; uveitis; vasculitis.
Similar articles
-
A case of aminoglycosides induced retinal toxicity treated with megadoses of steroids and an intravitreal dexamethasone implant (Ozurdex(®)).Arch Soc Esp Oftalmol. 2016 Jun;91(6):288-91. doi: 10.1016/j.oftal.2016.01.017. Epub 2016 Feb 24. Arch Soc Esp Oftalmol. 2016. PMID: 26922137 English, Spanish.
-
SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428. Eur J Ophthalmol. 2011. PMID: 21500185
-
Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling.Eur J Ophthalmol. 2015 Jul 30;25(5):e98-e100. doi: 10.5301/ejo.5000599. Eur J Ophthalmol. 2015. PMID: 25790811
-
POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.Retin Cases Brief Rep. 2018 Winter;12(1):75-79. doi: 10.1097/ICB.0000000000000433. Retin Cases Brief Rep. 2018. PMID: 27749791
-
The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):160-4. doi: 10.3928/23258160-20140131-03. Epub 2014 Feb 7. Ophthalmic Surg Lasers Imaging Retina. 2014. PMID: 24506098 Review.
Cited by
-
Case report: Camrelizumab associated with central retinal vein occlusion.Front Immunol. 2022 Nov 23;13:1025125. doi: 10.3389/fimmu.2022.1025125. eCollection 2022. Front Immunol. 2022. PMID: 36505454 Free PMC article.
-
Treatment of non-infectious retinal vasculitis.Ther Adv Ophthalmol. 2023 Feb 13;15:25158414231152761. doi: 10.1177/25158414231152761. eCollection 2023 Jan-Dec. Ther Adv Ophthalmol. 2023. PMID: 37077655 Free PMC article. Review.
-
Tuberculosis reactivation demonstrated by choroiditis and inflammatory choroidal neovascular membrane in a patient treated with immune checkpoint inhibitors for malignant mucosal melanoma.J Ophthalmic Inflamm Infect. 2023 Dec 18;13(1):54. doi: 10.1186/s12348-023-00374-x. J Ophthalmic Inflamm Infect. 2023. PMID: 38110833 Free PMC article.
-
[Ocular side effects of modern oncological therapy : Immunological checkpoint and MEK/BRAF signal transduction inhibitors].Ophthalmologie. 2023 May;120(5):559-573. doi: 10.1007/s00347-023-01852-2. Epub 2023 May 9. Ophthalmologie. 2023. PMID: 37160621 German.
-
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.Int J Mol Sci. 2020 May 11;21(9):3389. doi: 10.3390/ijms21093389. Int J Mol Sci. 2020. PMID: 32403289 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
